PREVENTIVE. Fetus and newborn affected by chorioamnionitis: Amnionitis
Conditions
Interventions
Intervention 1: in intervention group DW10% 60ml/kg/d will be prescribed and increases by 20ml/kg/d till 100ml/kg/d. sodium chloride 3meq/kg/d and potassium chloride 2meq/kg/d will be added to fluid f
Prevention
Treatment - Drugs
in intervention group DW10% 60ml/kg/d will be prescribed and increases by 20ml/kg/d till 100ml/kg/d. sodium chloride 3meq/kg/d and potassium chloride 2meq/kg/d will be added to fluid from second day o
in control group DW10% 60ml/kg/d will be prescribed and increases by 20ml/kg/d till 100ml/kg/d. sodium chloride 3meq/kg/d and potassium chloride 2meq/kg/d will be added to fluid from second day of lif
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Days
Inclusion criteria
Inclusion criteria: Inclusion Criteria: gestational age 34- 0/7 and 41- 6/7; respiratory rate>60/min at first 6 hours of life; persistence of tachypnea for at least 12 hours; appropriate radiographic findings for transient tachypnea of newborns; absence of history of meconium staining; fetal distress; mother's fever; rupture of membrane>18 hours Exclusion Criteria: blood sugar60%; hemoglobin20000/cumm; absolute neutrophil counts0.2; platelet counts10mg/ml
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of admission. Timepoint: discharge. Method of measurement: hour. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of NCPAP therapy. Timepoint: Continuous. Method of measurement: Hour.;Oxygen therapy. Timepoint: Continuous. Method of measurement: Hour. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoud Dehdashtian
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed